Acumen Pharmaceuticals, Inc. (ABOS)
NASDAQ: ABOS · IEX Real-Time Price · USD
3.650
-0.080 (-2.14%)
At close: May 17, 2024, 4:00 PM
3.700
+0.050 (1.37%)
After-hours: May 17, 2024, 7:51 PM EDT
Acumen Pharmaceuticals Market Cap
Acumen Pharmaceuticals has a market cap or net worth of $218.84 million as of May 17, 2024. Its market cap has decreased by -6.92% in one year.
Market Cap
218.84M
Enterprise Value
-3.32M
1-Year Change
-6.92%
Ranking
Category
Stock Price
$3.65
Market Cap Chart
Since the IPO on July 1, 2021, Acumen Pharmaceuticals's market cap has decreased from $618.43M to $218.84M, a decrease of -64.61%. That is a compound annual growth rate of -30.29%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
May 17, 2024 | 219.30M | -2.14% |
May 16, 2024 | 224.10M | -1.84% |
May 15, 2024 | 228.30M | 2.98% |
May 14, 2024 | 221.70M | 9.81% |
May 13, 2024 | 201.90M | - |
May 10, 2024 | 201.90M | -5.87% |
May 9, 2024 | 214.50M | 4.99% |
May 8, 2024 | 204.30M | 1.19% |
May 7, 2024 | 201.90M | -5.61% |
May 6, 2024 | 213.90M | 2.00% |
May 3, 2024 | 209.70M | 0.29% |
May 2, 2024 | 209.10M | 7.07% |
May 1, 2024 | 195.30M | 0.93% |
Apr 30, 2024 | 193.50M | 1.26% |
Apr 29, 2024 | 191.10M | 0.31% |
Apr 26, 2024 | 190.50M | -0.63% |
Apr 25, 2024 | 191.70M | 0.31% |
Apr 24, 2024 | 191.10M | 0.63% |
Apr 23, 2024 | 189.90M | 1.01% |
Apr 22, 2024 | 188.00M | -0.69% |
Apr 19, 2024 | 189.30M | -0.32% |
Apr 18, 2024 | 189.90M | -8.92% |
Apr 17, 2024 | 208.50M | -0.86% |
Apr 16, 2024 | 210.30M | -0.85% |
Apr 15, 2024 | 212.10M | -5.61% |
View and export this data all the way back to 2021.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Ovid Therapeutics | 223.48M |
Prelude Therapeutics | 222.46M |
Compass Therapeutics | 220.14M |
Merrimack Pharmaceuticals | 220.01M |
Innate Pharma | 219.07M |
Boundless Bio | 218.32M |
Butterfly Network | 217.01M |
INmune Bio | 216.82M |